sellModerate cluster of 3
Bluestone Jeffrey sold $620k of GILD
director at GILEAD SCIENCES, INC.. 6,788 shares at an average of $91.39, traded Nov 26, 2024, filed Nov 27, 2024.
Warning score
45Value
$620k
6,788 shares
Holdings after
8,920
-43% from before
From 52-week low
-
no price yet
From 52-week high
-
no price yet
Score components
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Rows in this filing
Every transaction in Form 4 0001127602-24-028213, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Nov 26, 2024 | MOption exercise Common Stock | +5,879 | $61.17 | $360k | 11,587 | Nov 27, 2024 |
| Nov 26, 2024 | MOption exercise Common Stock | +4,121 | $61.35 | $253k | 15,708 | Nov 27, 2024 |
| Nov 26, 2024 | SOpen-market sale Common Stock | -6,788 | $91.39 | $620k | 8,920 | Nov 27, 2024 |
| Nov 26, 2024 | MOption exercise Non-qualified Stock Option (Right to Buy)derivative | -5,879 | $0.00 | $0 | 0 | Nov 27, 2024 |
| Nov 26, 2024 | MOption exercise Non-qualified Stock Option (Right to Buy)derivative | -4,121 | $0.00 | $0 | 11,730 | Nov 27, 2024 |
Related signals
Other insiders at GILEAD SCIENCES, INC. and this insider’s other filings.
| Score | Side | Company | Insider | Value | Shares | Filed |
|---|---|---|---|---|---|---|
| 16Weak | sell10b5-1 | GILD GILEAD SCIENCES, INC. | Dickinson Andrew D Chief Financial Officer | $276k | 2,500 | |
| 12Weak | sell10b5-1 | GILD GILEAD SCIENCES, INC. | Dickinson Andrew D Chief Financial Officer | $2.1M | 17,929 | |
| 15Weak | sell10b5-1 | GILD GILEAD SCIENCES, INC. | Dickinson Andrew D Chief Financial Officer | $260k | 2,500 | |
| 22Weak | sell10b5-1 | GILD GILEAD SCIENCES, INC. | Dickinson Andrew D Chief Financial Officer | $14M | 137,676 | |
| 32Weak | sell10b5-1 | GILD GILEAD SCIENCES, INC. | Dickinson Andrew D Chief Financial Officer | $14M | 142,180 | |
| 15Weak | sell10b5-1 | GILD GILEAD SCIENCES, INC. | Dickinson Andrew D Chief Financial Officer | $228k | 2,500 | |
| 24Weak | sell10b5-1 | GILD GILEAD SCIENCES, INC. | Dickinson Andrew D Chief Financial Officer | $782k | 8,500 | |
| 47Moderate | sell 310b5-1 | GILD GILEAD SCIENCES, INC. | Dickinson Andrew D Chief Financial Officer | $23M | 248,645 | |
| 40Moderate | sell 310b5-1 | GILD GILEAD SCIENCES, INC. | Parsey Merdad Chief Medical Officer | $15M | 164,211 | |
| 18Weak | sell 210b5-1 | GILD GILEAD SCIENCES, INC. | Parsey Merdad Chief Medical Officer | $2.3M | 25,590 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.